5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.25▲ | 5.25▲ | 5.25▲ | 5.04▼ | 4.81▲ |
MA10 | 5.05▲ | 5.05▲ | 5.03▲ | 5.01▼ | 4.65▲ |
MA20 | 5.15▲ | 5.17▲ | 5.14▲ | 4.86▲ | 4.52▲ |
MA50 | 4.92▲ | 4.77▲ | 4.75▲ | 4.68▲ | N/A |
MA100 | 4.76▲ | 4.81▲ | 4.81▲ | 4.61▲ | N/A |
MA200 | 4.71▲ | 4.67▲ | 4.92▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.026▲ | 0.017▲ | 0.015▲ | 0.007▲ | 0.088▲ |
RSI | 63.113▲ | 62.407▲ | 61.841▲ | 51.563▲ | 50.604▲ |
STOCH | 98.023▲ | 91.242▲ | 74.875 | 36.692 | 42.841 |
WILL %R | 0.000▲ | 0.000▲ | -3.046▲ | -69.368 | -53.538 |
CCI | 184.306▲ | 159.968▲ | 131.394▲ | -32.091 | 71.867 |
Monday, August 04, 2025 07:08 AM
RADX READ THE FULL RADX RESEARCH REPORT Since our May initiation of Radiopharm Theranostics Limited (NASDAQ:RADX), the company has provided several progress updates. Two radionuclide supply agreements ...
|
Tuesday, July 29, 2025 06:19 AM
In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...
|
Monday, July 21, 2025 11:21 PM
Fintel reports that on July 21, 2025, Brookline Capital initiated coverage of Radiopharm Theranostics Limited - Depositary Receipt () (NasdaqCM:RADX) with a Buy recommendation. Analyst Price ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 5.00 | 5.00 | 4.80 | 4.89 | 6,500 |
14/08/25 | 5.0133 | 5.1512 | 4.72 | 5.015 | 22,916 |
13/08/25 | 5.33 | 5.73 | 5.21 | 5.38 | 12,200 |
12/08/25 | 4.60 | 5.215 | 4.545 | 5.215 | 50,000 |
11/08/25 | 4.63 | 4.90 | 4.62 | 4.71 | 11,000 |
08/08/25 | 5.2889 | 5.2889 | 4.63 | 4.675 | 8,304 |
07/08/25 | 4.9625 | 5.50 | 4.67 | 4.85 | 14,827 |
06/08/25 | 4.75 | 5.049 | 4.59 | 5.049 | 18,500 |
05/08/25 | 4.934 | 5.40 | 4.875 | 5.25 | 29,315 |
04/08/25 | 5.6499 | 5.6499 | 4.9956 | 5.025 | 23,325 |
|
|
||||
|
|
||||
|
|